182 related articles for article (PubMed ID: 34983677)
1. PET/CT variants and pitfalls in malignant melanoma.
Aide N; Iravani A; Prigent K; Kottler D; Alipour R; Hicks RJ
Cancer Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983677
[No Abstract] [Full Text] [Related]
2. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
Kumar R; Alavi A
Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921
[TBL] [Abstract][Full Text] [Related]
3. Rational use of
Bisschop C; de Heer EC; Brouwers AH; Hospers GAP; Jalving M
Crit Rev Oncol Hematol; 2020 Sep; 153():103044. PubMed ID: 32673997
[No Abstract] [Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies.
Lee ST; Kovaleva N; Senko C; Kee D; Scott AM
PET Clin; 2024 Apr; 19(2):231-248. PubMed ID: 38233284
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose-PET in the management of malignant melanoma.
Kumar R; Mavi A; Bural G; Alavi A
Radiol Clin North Am; 2005 Jan; 43(1):23-33. PubMed ID: 15693645
[TBL] [Abstract][Full Text] [Related]
7. CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.
Barat M; Guegan-Bart S; Cottereau AS; Guillo E; Hoeffel C; Barret M; Gaujoux S; Dohan A; Soyer P
Abdom Radiol (NY); 2021 May; 46(5):2219-2235. PubMed ID: 33135115
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
Annunziata S; Laudicella R; Caobelli F; Pizzuto DA; Aimn Working Group Y
Curr Radiopharm; 2020; 13(1):6-13. PubMed ID: 31749438
[TBL] [Abstract][Full Text] [Related]
9.
Hicks RJ; Iravani A; Sandhu S
PET Clin; 2020 Jan; 15(1):11-22. PubMed ID: 31735298
[TBL] [Abstract][Full Text] [Related]
10. BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET/CT in Patients With Malignant Melanoma.
Aljared A; Alharbi AA; Huellner MW
Clin Nucl Med; 2018 May; 43(5):370-371. PubMed ID: 29485444
[TBL] [Abstract][Full Text] [Related]
11. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
[No Abstract] [Full Text] [Related]
12. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
13. The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art.
Castello A; Lopci E
Curr Radiopharm; 2020; 13(1):24-31. PubMed ID: 31749440
[TBL] [Abstract][Full Text] [Related]
14. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.
Dietlein M; Krug B; Groth W; Smolarz K; Scheidhauer K; Psaras T; Stützer H; Lackner K; Schicha H
Nucl Med Commun; 1999 Mar; 20(3):255-61. PubMed ID: 10093075
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
Wachsmann JW; Ganti R; Peng F
Acad Radiol; 2017 Jan; 24(1):111-115. PubMed ID: 27818005
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic impact of
Tatar G; Alçin G; Sengul Samanci N; Erol Fenercioglu Ö; Beyhan E; Cermik TF
Clin Transl Oncol; 2022 Oct; 24(10):1903-1913. PubMed ID: 35594002
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of positron emission tomography for the detection of melanoma metastases.
Holder WD; White RL; Zuger JH; Easton EJ; Greene FL
Ann Surg; 1998 May; 227(5):764-9; discussion 769-71. PubMed ID: 9605668
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral viral pneumonia by COVID-19 as a chance finding in staging with
Gómez-Caminero-López F; García-Talavera-San-Miguel P; Lucas Velázquez B; García Arroyo J; Díaz González LG; Gómez Grande A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):316-317. PubMed ID: 32487445
[No Abstract] [Full Text] [Related]
20. The clinical use of PET/CT in the evaluation of melanoma.
Keu KV; Iagaru AH
Methods Mol Biol; 2014; 1102():553-80. PubMed ID: 24258999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]